040102052026 CLEMASTINA 1MG COMP
About This Opportunity
TranslatedThis tender pertains to the procurement of CLEMASTINA 1MG COMP, a medication used for the treatment of allergic conditions. The tender is likely issued by a government health agency or a public procurement body responsible for the acquisition of pharmaceuticals. Key requirements for bidders may include compliance with regulatory standards for drug manufacturing and distribution, as well as the ability to provide the product in specified quantities and within a defined timeframe. It is essential for bidders to demonstrate their capacity to meet quality assurance protocols and provide necessary documentation, such as certificates of analysis and product registration. The location of the tender is not explicitly mentioned, but it is expected to be relevant to the jurisdiction of the issuing authority. This procurement is crucial for ensuring the availability of essential medications in the healthcare system, particularly for patients requiring treatment for allergies. Interested suppliers should prepare to submit their proposals in accordance with the guidelines provided in the tender documents, which will detail submission deadlines, evaluation criteria, and any other pertinent information. Overall, this tender represents an important opportunity for pharmaceutical companies to contribute to public health initiatives by supplying a vital medication.
This is a supplies contract in the health and medical services and trade and industry sectors, with a focus on Pharmaceuticals, Manufacturing and Quality Standards. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 1,320.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThis tender, identified as 040102052026, pertains to the procurement of CLEMASTINA 1MG COMP, a pharmaceutical product, in Portugal. The contracting authority, although not specified in the available documentation, operates within the framework of public procurement, which aims to enhance the efficiency and transparency of acquiring goods and services for public health entities.
CLEMASTINA, an antihistamine used to alleviate allergy symptoms, is a critical component in the healthcare sector, particularly in response to seasonal and chronic allergic conditions. This tender highlights the need for suppliers to provide this medication in compliance with established pharmaceutical regulations and standards. Typical requirements for such tenders include adherence to rigorous quality control measures, proof of certification, and compliance with Good Manufacturing Practices (GMP).
Interested bidders are expected to demonstrate their capacity to supply the specified product consistently and reliably, ensuring timely delivery aligned with the healthcare provider's needs. Furthermore, suppliers may be required to provide detailed documentation regarding the sourcing and manufacturing processes of the product to guarantee safety and efficacy.
Bidders should also be prepared to engage in negotiations pertaining to pricing, delivery schedules, and potential volume discounts, as well as addressing any regulatory compliance issues that may arise during the procurement process. This tender represents an essential opportunity for pharmaceutical suppliers to contribute to public health initiatives in Portugal while adhering to the principles of fair competition and transparency in public procurement.
Data provenance
This notice is sourced from base_gov_pt and was originally published on February 11, 2026. Last refreshed 6 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde de Coimbra, EPE
Unidade Local de Saúde de Coimbra, EPE has issued 892 procurement notices on BidsFactory, including 6 currently open and 846 awarded contracts. Activity concentrates in General Supplies & Services, Health & Medical, and Governance & Public Administration. All notices are published for Portugal. Notices are distributed via base_gov_pt and TED - Tenders Electronic Daily (EU). Most recent publication: June 18, 2026.
Frequently asked questions about this tender
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to CICLUM FARMA UNIPESSOAL, LDA. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde de Coimbra, EPE in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €1,320. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.